216 related articles for article (PubMed ID: 34367948)
1. Multi-Omic Analyses of the m
Xue C; Zhao Y; Li G; Li L
Front Oncol; 2021; 11():633415. PubMed ID: 34367948
[TBL] [Abstract][Full Text] [Related]
2. ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma.
Wang ZZ; Meng T; Yang MY; Wang W; Zhang Y; Liu Y; Han AQ; Wu J; Wang HX; Qian B; Zhu LX
Transl Oncol; 2022 Jul; 21():101441. PubMed ID: 35523010
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract][Full Text] [Related]
4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
5. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
6. Role of m
He Y; Yu X; Li J; Zhang Q; Zheng Q; Guo W
Am J Transl Res; 2020; 12(3):912-922. PubMed ID: 32269723
[TBL] [Abstract][Full Text] [Related]
7. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
8. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
Wang M; Wang L; Wu S; Zhou D; Wang X
Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
[TBL] [Abstract][Full Text] [Related]
10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
11. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
[TBL] [Abstract][Full Text] [Related]
13. Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
Liang TT; Shao Q; Deng ZC; Wang T; Kang QZ
Front Genet; 2020; 11():847. PubMed ID: 32973867
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.
Xu M; Xu J; Zhu D; Su R; Zhuang B; Xu R; Li L; Chen S; Ling Y
J Transl Med; 2021 Mar; 19(1):126. PubMed ID: 33771165
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
[TBL] [Abstract][Full Text] [Related]
16. Identifying drug candidates for hepatocellular carcinoma based on differentially expressed genes.
Xing J; Shi Q; Zhao J; Yu Z
Am J Transl Res; 2020; 12(6):2664-2674. PubMed ID: 32655798
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.
Zheng Q; Fu Q; Xu J; Gu X; Zhou H; Zhi C
J Cancer; 2021; 12(6):1792-1803. PubMed ID: 33613768
[No Abstract] [Full Text] [Related]
18. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract][Full Text] [Related]
19. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J
Front Oncol; 2021; 11():626663. PubMed ID: 34336642
[TBL] [Abstract][Full Text] [Related]
20. Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.
Li C; Xu J
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
